Gut-specific inhibition of PPARα as a novel approach of NAFLD treatment
Hepatology
.
2022 May 27.
doi: 10.1002/hep.32592.
Online ahead of print.
Authors
Lanjing Zhang
1
2
3
,
Grace L Guo
4
5
Affiliations
1
Department of Pathology, Princeton Medical Center, Plainsboro, New Jersey, USA.
2
Department of Biological Sciences, Rutgers University, Newark, New Jersey, USA.
3
Department of Chemical Biology, Ernst Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA.
4
Department of Pharmacology and Toxicology, Ernst Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA.
5
Research and Development Service, Veterans Health Administration, New Jersey Health Care System, East Orange, New Jersey, USA.
PMID:
35633082
DOI:
10.1002/hep.32592
No abstract available
Publication types
Editorial